CME/CE Quiz

CME/CE QUESTIONS

Continuing Medical Education Accreditation

The University of Cincinnati College of Medicine designates this educational activity for a maximum of 2 Category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those hours that he/she actually spends in the educational activity.

The University of Cincinnati College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor medical education for physicians.

Continuing Pharmacy Education Accreditation

Pharmacy Times

is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is approved for 2 contact hours (0.2 CEU) under the ACPE universal program number of 290-999-04-026-H01.

Instructions After reading "Current Trends for the Management and Treatment of Depression," complete the program evaluation and select the 1 best answer to each of the following questions. A statement of continuing education hours will be mailed to those who successfully complete (a minimum score of 70%) the examination at the conclusion of the program.

Lack of adequate healthcare coverage

• Patients' aversion to taking medications

Stigma and lack of systemic screening

• Presence of other comorbid conditions

Adequate

• Inadequate

Excessive

• Multiple

Cardiovascular illnesses

• Alcoholism and smoking

Viral and bacterial infections

• Sexually transmitted diseases

Report data on the duration of antidepressant drug therapy

• Report physicians who do not discuss antidepressant therapy with patients

Share patient information with other plans

• None of the above

True

• False

Request brand name antidepressants rather than generic formulations

• Take more antidepressants than prescribed

Visit the doctor's office excessively

• Switch and augment their antidepressants

True

• False

Improve

• Not affect

Stabilize

• Reduce
• Between 2% and 4%

Between 5% and 10%

• More than 25%

More than 50%

• Approximately 75%

They have impairment in quality of life

• They have increased mortality

They are poor candidates for selective serotonin reuptake inhibitor (SSRI) therapy

• They have increased platelet activation

Between 2% and 6%

• Between 10% and 25%

More than 25%

• More than 50%

5%

• 10%

25%

• 30%

Greater overall impairment in quality of life

• Fail to adhere to treatment up to 3 times more often than nondepressed patients

Often benefit from SSRI antidepressant medication

• All of the above

Pharmacokinetic and pharmacodynamic properties

• Intended therapeutic indication

Both a and b

• Neither a or b

Catastrophic illnesses and outcomes

• No particular outcome

Neurological disorders

• Cardiovascular disorders

Without a prescription

• Improperly

For longer periods of time

• All of the above

Tricyclic antidepressants

• SSRIs

CYP enzyme inhibitors

• Quinolones

Mandate switching from a branded drug to a generic formulation

• Keep medication regimens simple

Select drugs for formulary based on acquisition costs

• Avoid costly software programs to screen patients for potential DDIs

No

• 3

5

• 6 or more

True

• False

For Pharmacists

ANSWER CARD INSTRUCTIONS

Testing and Grading Procedures

• Each participant achieving a passing grade of 70% or higher on any examination will receive an official computer form stating the number of CE credits earned. This form should be safeguarded and may be used as documentation of credits earned.

Participants receiving a failing grade on any exam will be notified and permitted to take 1 reexamination at no cost.

• All answers should be recorded on the answer form. Please print clearly to ensure receipt of CE credit.

Pharmacy Times

To receive credit certification electronically, please provide your e-mail address. Detach and mail completed exam form with your $10.00 payment to CE Department, 405 Glenn Drive, Suite 4, Sterling, VA 20164-4432; or fax to 703-404-1801.

• Take the test online with a $5.00 payment at www.pharmacytimes. com and receive immediate grading and CE credits, and download your CE statement of credit.

Please photocopy the test form for additional test takers

Pharmacy Times

is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is approved for 2 contact hours (0.2 CEUs) under the ACPE universal program number of 290-999-04-026-H01. The program is available for CE credit through July 31, 2005.

Current Trends for the Management and Treatment of Depression

GOAL

To provide participants with an update on the current treatment trends for depression management and their impact on patients, costs, and managed care organizations.

TARGET AUDIENCE

This activity is designed for psychiatrists, physicians in primary care, pharmacists, medical directors, pharmacy directors, group practice directors, hospital directors, home healthcare directors, and other managed care decision makers.

EDUCATIONAL OBJECTIVES

After completing this continuing education activity, the participant should be able to:

• Describe the challenges of managing antidepressant drug therapy in an evolving marketplace.

Discuss the recent developments in antidepressant therapy for special populations.

• Explain how drug—drug interactions and drug switching can impact patients, costs, and managed care organizations.

CONTINUING MEDICAL EDUCATION ACCREDITATION

The University of Cincinnati College of Medicine designates this activity for a maximum of 2 Category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spends in the educational activity.

The University of Cincinnati College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor medical education for physicians. Release Date: July 31, 2004. Expiration Date: July 31, 2005.

CONTINUING PHARMACY EDUCATION ACCREDITATION

Pharmacy Times

is accredited by the Accreditation Council on Pharmacy Education as a provider of continuing pharmacy education. This program is approved for 2 contact hours (0.2 CEUs) under the ACPE universal program number of 290-999-04-026-H01. Release Date: July 31, 2004. Expiration Date: July 31, 2005.

FUNDING This program is supported by an unrestricted educational grant from Pfizer.

Download PDF: CME/CE Quiz